Investor Says Stereotaxis Hid Problems With Products

Law360, New York (October 11, 2011, 3:57 PM EDT) -- Stereotaxis Inc. was hit with a putative shareholder class action in Missouri on Friday claiming the medical device maker hid problems with its flagship cardiology treatment systems, resulting in nearly $10 million in losses and the resignation of its chief financial officer.

The suit, filed on behalf of investors who purchased securities between Feb. 28 and Aug. 9, claims Stereotaxis puffed up reports on the demand for its Niobe and Odyssey systems, telling investors the company had an edge on the market and that customer feedback...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Pound v. Stereotaxis, Inc. et al


Case Number

4:11-cv-01752

Court

Missouri Eastern

Nature of Suit

Securities/Commodities

Judge

Henry E. Autrey

Date Filed

October 7, 2011

Law Firms

Companies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.